1. Shimizu, Dai, Kanda, Mitsuro, Kishida, Takayoshi, Motoyama, Satoru, Kodera, Yasuhiro. . OPLAH Protein Expression Stratifies the Prognosis of Patients With Squamous Cell Carcinoma of the Esophagus. In Cancer genomics & proteomics, 20, 343-353. doi:10.21873/cgp.20386. https://pubmed.ncbi.nlm.nih.gov/37400143/
2. Bachhawat, Anand K, Yadav, Shambhu, Jainarayanan, Ashwin K, Dubey, Pratiksha. . Heart failure and the glutathione cycle: an integrated view. In The Biochemical journal, 477, 3123-3130. doi:10.1042/BCJ20200429. https://pubmed.ncbi.nlm.nih.gov/32886767/
3. van der Pol, Atze, Gil, Andres, Silljé, Herman H W, Bischoff, Rainer, van der Meer, Peter. . Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH. In Science translational medicine, 9, . doi:10.1126/scitranslmed.aam8574. https://pubmed.ncbi.nlm.nih.gov/29118264/
4. Calpena, Eduardo, Casado, Mercedes, Martínez-Rubio, Dolores, Artuch, Rafael, Espinós, Carmen. 2012. 5-Oxoprolinuria in Heterozygous Patients for 5-Oxoprolinase (OPLAH) Missense Changes. In JIMD reports, 7, 123-8. doi:10.1007/8904_2012_166. https://pubmed.ncbi.nlm.nih.gov/23430506/
5. Kasapkara, Çiğdem Seher, Kıreker Köylü, Oya, Engin Erdal, Ayşenur, Ceylan, Nesrin, Ceylaner, Serdar. 2024. Is 5-Oxoprolinase Deficiency More than Just a Benign Condition? In Molecular syndromology, 15, 303-310. doi:10.1159/000536295. https://pubmed.ncbi.nlm.nih.gov/39129838/